U.S. drug regulators on Wednesday issued an emergency use authorization for the first oral antiviral coronavirus pill, developed by pharmaceutical giant Pfizer Inc.The pill, called Paxlovid, is authorized for mild-to-moderate coronavirus cases in patients aged 12 or older facing high risk of severe illness, and can be taken at home. The company is ready to ship limited supplies of the treatment, whose complex production process requires six to eight months for each batch."Everyone agrees this is a very promising antiviral, and therefore, we want to make sure that production is ramped up as …READ FULL ARTICLE
